SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-24-088546
Filing Date
2024-08-12
Accepted
2024-08-12 21:49:17
Documents
2
Period of Report
2024-08-12

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2420079-5_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2420079-5_3seq1.xml 3 4405
2 EXHIBIT 24 tm2420079d5_ex24.htm EX-24 3509
  Complete submission text file 0001104659-24-088546.txt   9581
Mailing Address 1751 RIVER RUN SUITE 400 FORT WORTH TX 76107
Business Address 1751 RIVER RUN SUITE 400 FORT WORTH TX 76107 847-986-4190
ACTUATE THERAPEUTICS, INC. (Issuer) CIK: 0001652935 (see all company filings)

IRS No.: 473044785 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O APEXIGEN INC 75 SHOREWAY ROAD, SUITE C SAN CARLOS CA 94070
Business Address
Zabrowski Dan (Reporting) CIK: 0001940818 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-42139 | Film No.: 241198558